# Bionano to Report First Quarter 2026 Financial Results and Host a Conference Call Webcast on May 13, 2026
Canonical URL: https://biopharmsignal.com/news/BNGO/bionano-to-report-first-quarter-2026-financial-results-and-host-a-conference-call-webcast-on-may-13-2026
Ticker: BNGO
Company: BioNano Genomics
Source: BioNano Genomics
Published: 2026-04-29 20:05 EST
Original Source URL: https://ir.bionanogenomics.com
## Summary

SAN DIEGO, April 29, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it will host a conference call and live webcast on Wednesday, May 13, 2026, at 4:30 p.m. Eastern Time to report financial results for the first quarter 2026 and to highlight recent corporate

## Article Body
SAN DIEGO, April 29, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it will host a conference call and live webcast on Wednesday, May 13, 2026, at 4:30 p.m. Eastern Time to report financial results for the first quarter 2026 and to highlight recent corporate
## Recent Company News
- 2026-05-28 12:00 EST — [Bionano Announces Full Retirement of Outstanding Senior Secured Convertible Debentures](https://biopharmsignal.com/news/BNGO/bionano-announces-full-retirement-of-outstanding-senior-secured-convertible-debentures) — Source: BioNano Genomics
- 2026-05-26 12:00 EST — [Bionano Announces Largest OGM Study of T-Cell Acute Lymphoblastic Leukemia](https://biopharmsignal.com/news/BNGO/bionano-announces-largest-ogm-study-of-t-cell-acute-lymphoblastic-leukemia) — Source: BioNano Genomics
- 2026-05-13 20:05 EST — [Bionano Reports First Quarter 2026 Results and Provides a Business Update](https://biopharmsignal.com/news/BNGO/bionano-reports-first-quarter-2026-results-and-provides-a-business-update) — Source: BioNano Genomics
- 2026-05-06 20:30 EST — [Bionano Announces Leadership Transition](https://biopharmsignal.com/news/BNGO/bionano-announces-leadership-transition) — Source: BioNano Genomics
- 2026-05-05 12:00 EST — [Bionano Announces a 56% Increase in Publications Describing the Utility of OGM in Rare Diseases in Q1 2026 vs Q1 2025](https://biopharmsignal.com/news/BNGO/bionano-announces-a-56-increase-in-publications-describing-the-utility-of-ogm-in-rare-diseases-in-q1-2026-vs-q1-2025) — Source: BioNano Genomics
## Related News
- 2026-07-21 12:05 EST — VRCA — [Verrica Pharmaceuticals and Medomie Pharma Enter into Exclusive Distribution, Marketing and Supply Agreement to Commercialize YCANTH® for the Treatment of Molluscum Contagiosum in Israel](https://biopharmsignal.com/news/VRCA/verrica-pharmaceuticals-and-medomie-pharma-enter-into-exclusive-distribution-mar-abf61522)
- 2026-07-21 11:30 EST — ABEO — [Cincinnati Children's Activated as the Seventh Qualified Treatment Center for ZEVASKYN®](https://biopharmsignal.com/news/ABEO/cincinnati-children-s-activated-as-the-seventh-qualified-treatment-center-for-ze-8382d043)
- 2026-07-21 10:28 EST — GSK — [ViiV Healthcare to present phase IIIb data comparing Dovato with Biktarvy in treatment-naïve adults alongside INSTI-powered long-acting injectable innovation at AIDS 2026](https://biopharmsignal.com/news/GSK/viiv-healthcare-to-present-phase-iiib-data-comparing-dovato-with-biktarvy-in-tre-1ff3f640)
- 2026-07-20 20:05 EST — RANI — [Rani Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)](https://biopharmsignal.com/news/RANI/rani-therapeutics-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4-ec56b3b0)
- 2026-07-20 14:53 EST — IPHA — [Innate Pharma announces Completion of Enrollment in Phase 1 Dose Escalation Study of IPH4502, a Novel Nectin-4 Exatecan Antibody-Drug Conjugate (ADC)](https://biopharmsignal.com/news/IPHA/innate-pharma-announces-completion-of-enrollment-in-phase-1-dose-escalation-stud-0778493f)